CertaraCERT +6.38%54 Buyback Yield % is 9.16 as of Jun. 28, 2026, which is 452% above its 10-year median of 1.66. GuruFocus rates CERT with a GF Score™ of 54/100 and a GF Value™ of $13.40 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Certara ranks better than 95.94% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Certara's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CERT vs TALK, GDRX, OMDA: Buyback Yield % Comparison
For the Health Information Services subindustry, Certara's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Certara Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Certara's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Certara's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Certara (CERT) has a Buyback Yield % of 9.16 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Certara and its competitors. This is 452% above median its historical median of 1.66. According to the industry distribution chart, Certara ranks #11 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 4.1%.
Is Certara's Buyback Yield % too high?
Certara's current Buyback Yield % of 9.16 is 452% above median its 10-year median of 1.66. Based on the distribution chart, Certara ranks #11 out of 271 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Certara has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Certara's Buyback Yield % compare to TALK and GDRX?
According to the Healthcare Providers & Services industry distribution chart, Certara ranks #11 out of 271 companies for Buyback Yield %. This places Certara in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Certara and its competitors. Certara's current Buyback Yield % is 9.16, which is 452% above median its own 10-year median of 1.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certara stock overvalued right now?
Based on GuruFocus' analysis, Certara (CERT) is currently considered Possible Value Trap. The stock's GF Value™ is $13.40, compared to a current price of $5.80 — trading 56.8% below its estimated fair value. The current Buyback Yield % is 9.16, which is 452% above median its 10-year median of 1.66. Certara's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Certara (CERT), the current Buyback Yield % is 9.16 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Certara (CERT) Overvalued in 2026?
Based on GuruFocus' analysis, Certara stock appears to be undervalued.
The current stock price of $5.80 is trading 56.8% below its estimated GF Value™ of $13.40.
GuruFocus considers Certara to be Possible Value Trap.
Key valuation signals for CERT:
Buyback Yield %: 9.16 (452% above median its 10-year median of 1.66)
GF Value™: $13.40 vs. price of $5.80 (56.8% below fair value)
No single metric tells the full story. See the CERT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
54GF Score
Get the complete analysis for CERT
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CERT has been successfully added to your 
